TCM
PFE icon

Tamarack Capital Management’s Pfizer PFE Stock Holding History

Tamarack Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-474,300
Closed -$14M – 44
2014
Q4 		$14M Buy
474,300
+52,700
+13% +$1.51M 2.13% 16
2014
Q3 		$11.8M Buy
+421,600
New +$11.8M 2.62% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tamarack Capital Management's PFE Position: Q2 2015 in Review

Tamarack Capital Management sold out of Pfizer (PFE) in Q2 2015, closing a stake of 412,323 shares — an estimated $13.6M sold.

Tamarack Capital Management first reported a position in PFE in Q1 2015 and held it in 1 quarter. The position peaked at $13.6M in Q1 2015. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Tamarack Capital Management reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 412,323 Pfizer shares in Q2 2015, an estimated $13.6M.
  • Tamarack Capital Management first reported a position in Pfizer in Q1 2015 and held it in 1 quarter.
  • Tamarack Capital Management's Pfizer position peaked at $13.6M in Q1 2015.
  • 1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Tamarack Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.